Gyre Therapeutics (GYRE) Cash & Current Investments (2010 - 2026)
Gyre Therapeutics' Cash & Current Investments came in at $57.4 million for Q2 2026, up 5.5% from $54.4 million a year earlier and up 15.2% from the prior quarter.
Powered by 
Analysis
Gyre Therapeutics (GYRE) Cash & Current Investments (2010 - 2026) Analysis & Trends
At the end of FY2025, Gyre Therapeutics' Cash & Current Investments was $64.59 million, up 141.8% from FY2024.
- Cash & Current Investments carries a five-year compound annual growth rate of -4.6% (FY2020 to FY2025).
- Going back by year, Cash & Current Investments was $26.71 million in FY2024 (-20.3%), $33.51 million in FY2023 (+54.4%), $21.7 million in FY2022 (-53.7%) and $46.9 million in FY2021 (-42.7%).
- The five-year range for quarterly Cash & Current Investments is $2.23 million (Q3 2023) to $75.4 million (Q2 2022).
- Year-over-year, Cash & Current Investments has increased for five consecutive quarters, with growth averaging 61.3% over the last seven quarters.
- The fastest year-over-year change in Cash & Current Investments over five years came in Q1 2024 (growth of 361.7%), and the weakest in Q2 2023 (a decline of 90.8%).
- Business Quant data shows GYRE's Cash & Current Investments at $49.81 million (Q1 2026), $64.59 million (Q4 2025) and $60.05 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 20.76 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 7.14 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 9.92 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 4.97 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 11.70 Bn |
| 10 | Gyre Therapeutics | 753.90 Mn | 556.61 Mn | 26.90 Mn | 57.40 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 57.40 Mn |
| Mar 31, 2026 | 49.81 Mn |
| Dec 31, 2025 | 64.59 Mn |
| Sep 30, 2025 | 60.05 Mn |
| Jun 30, 2025 | 54.40 Mn |
| Mar 31, 2025 | 29.89 Mn |
| Dec 31, 2024 | 26.71 Mn |
| Sep 30, 2024 | 25.13 Mn |
| Jun 30, 2024 | 25.10 Mn |
| Mar 31, 2024 | 37.40 Mn |
| Dec 31, 2023 | 33.51 Mn |
| Sep 30, 2023 | 2.23 Mn |
| Jun 30, 2023 | 6.92 Mn |
| Mar 31, 2023 | 8.10 Mn |
| Dec 31, 2022 | 21.70 Mn |
| Sep 30, 2022 | 23.10 Mn |
| Jun 30, 2022 | 75.40 Mn |
| Mar 31, 2022 | 34.82 Mn |
| Dec 31, 2021 | 46.90 Mn |
| Sep 30, 2021 | 64.50 Mn |
API Access
Gyre Therapeutics Cash & Current Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=GYRE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-current-investments", "ticker": "GYRE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=GYRE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();